glargine
- Generic Name
- glargine
Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
- Conditions
- Type 1 Diabetes
- Interventions
- First Posted Date
- 2007-11-27
- Last Posted Date
- 2019-10-11
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT00564018
- Locations
- 🇺🇸
Children's Medical Center, Dallas, Texas, United States
24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine
- First Posted Date
- 2007-10-31
- Last Posted Date
- 2010-10-13
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 15
- Registration Number
- NCT00551538
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Indianapolis, Indiana, United States
Lispro Mix 25 vs. Glargine in Type 2 Diabetics
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- Drug: Insulin lispro mix 25
- First Posted Date
- 2007-10-31
- Last Posted Date
- 2007-10-31
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 53
- Registration Number
- NCT00551356
- Locations
- 🇲🇽
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mexico City, Mexico
Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
- Conditions
- Type 1 Diabetes
- Interventions
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT00505882
- Locations
- 🇺🇸
UT Southwestern at Dallas, Dallas, Texas, United States
One Year Glargine Treatment in CFRD Children and Adolescents
- Conditions
- Cystic FibrosisGlucose Metabolism Disorders
- First Posted Date
- 2007-06-07
- Last Posted Date
- 2007-06-07
- Lead Sponsor
- Federico II University
- Target Recruit Count
- 20
- Registration Number
- NCT00483769
- Locations
- 🇮🇹
Deptm of Pediatrics Regional Cystic Fibrosis Center- University of Naples - Federico II, Naples, Italy
A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2010-11-18
- Lead Sponsor
- Diabetes Care Center
- Target Recruit Count
- 35
- Registration Number
- NCT00457093
- Locations
- 🇺🇸
Diabetes Care Center, Salinas, California, United States
Use of Insulin Glargine to Treat Diabetic Ketoacidosis
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2018-07-16
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 75
- Registration Number
- NCT00179127
- Locations
- 🇺🇸
Vanderbilt University Monroe Carell Children's Hospital, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.